954239-03-3 Usage
Description
(2-AMINO-5-TRIFLUOROMETHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER is a chemical compound that serves as a building block in the synthesis of pharmaceuticals and agrochemicals. It is a carbamic acid ester with a carbamic acid functional group attached to a tert-butyl ester group. Known for its high stability and relatively low reactivity, this compound is a valuable intermediate in the production of a wide range of organic compounds. The trifluoromethyl group imparts unique electronic and steric properties to the molecule, while the amino group allows for potential interactions with biological targets, making it a valuable tool in medicinal chemistry.
Uses
Used in Pharmaceutical Industry:
(2-AMINO-5-TRIFLUOROMETHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a key intermediate in the synthesis of various pharmaceuticals for its potential to interact with biological targets and contribute to the development of new drugs.
Used in Agrochemical Industry:
(2-AMINO-5-TRIFLUOROMETHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a building block in the creation of agrochemicals, leveraging its stability and reactivity properties to produce compounds that can be applied in agricultural settings.
Used in Medicinal Chemistry Research:
(2-AMINO-5-TRIFLUOROMETHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER is utilized as a valuable tool in medicinal chemistry for exploring its interactions with biological targets and its potential applications in the design of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 954239-03-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,4,2,3 and 9 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 954239-03:
(8*9)+(7*5)+(6*4)+(5*2)+(4*3)+(3*9)+(2*0)+(1*3)=183
183 % 10 = 3
So 954239-03-3 is a valid CAS Registry Number.
954239-03-3Relevant articles and documents
HDAC3-SELECTIVE INHIBITORS
-
Page/Page column 28-29, (2019/01/05)
Disclosed herein are selective HDAC inhibitors. In some embodiments, the compounds are selective HDAC3 inhibitors. The compounds are useful to treat a variety of conditions, including cancers, i.e., breast cancer, cachexia, and liver steatosis.
